Figure 3.
Forest plot of the effect of MRD on relapse, RFS, and OS in the whole cohort for various subgroups. Relapse (A), RFS (B), and OS (C). MRDhigh: patients with WT1/100ABL >2.5% in BM or >0.5% in PB. MRDlow, patients with WT1/100ABL <2.5% in BM or <0.5% in PB. HR, hazard ratio. WBC count, 109/L. Pval: P-value; Yo, years old; Fav, favorable; Int, intermediate; Unfav, unfavorable. For NPM1 and FLT3-ITD mutations: 0, not mutated, and 1, mutated.

Forest plot of the effect of MRD on relapse, RFS, and OS in the whole cohort for various subgroups. Relapse (A), RFS (B), and OS (C). MRDhigh: patients with WT1/100ABL >2.5% in BM or >0.5% in PB. MRDlow, patients with WT1/100ABL <2.5% in BM or <0.5% in PB. HR, hazard ratio. WBC count, 109/L. Pval: P-value; Yo, years old; Fav, favorable; Int, intermediate; Unfav, unfavorable. For NPM1 and FLT3-ITD mutations: 0, not mutated, and 1, mutated.

Close Modal

or Create an Account

Close Modal
Close Modal